Internal Medicine · Statesville, NC
NPI
1245231430
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
349 Brookdale Dr
Statesville, NC, 28677
Phone (980) 223-2595
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
2,308 services
Medicare patients, 2024
112
Average age 68
Drug cost, 2024
$2.1M
10,823 prescriptions
Company payments, 2025
$4,911
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Menelaos Voulgaropoulos was code 99214 (office e&m - established), 313 times for 86 patients. In total Menelaos Voulgaropoulos billed 2,308 services in 99 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 313 | 86 | $76.65 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 270 | 76 | $12.13 | $3,274 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 203 | 35 | $39.06 | $7,929 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 126 | 16 | $0.71 | $90.07 |
| 80305 Drug Tests | Office | 120 | 25 | $12.25 | $1,470 |
| 99215 Office E&M - Established | Office | 110 | 54 | $121.59 | $13K |
| 81003 Clinical Chemistry | Office | 85 | 50 | $2.20 | $187 |
| 82947 Clinical Chemistry | Office | 75 | 30 | $3.85 | $289 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 59 | 59 | $119.34 | $7,041 |
| 83036 Blood Count | Office | 55 | 30 | $9.52 | $524 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 49 | 49 | $17.53 | $859 |
| 82044 Clinical Chemistry | Office | 49 | 34 | $6.11 | $299 |
| 82570 Clinical Chemistry | Office | 47 | 33 | $5.08 | $239 |
| 96127 Behavioral Health Services | Office | 41 | 22 | $2.76 | $113 |
| 96372 Injection Administration | Office | 30 | 19 | $9.57 | $287 |
By year: 2022 $80K for 1,831 services; 2023 $82K for 2,035 services; 2024 $78K for 2,308 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 120 | 25 | $12.25 | $1,470 |
| 81003 Clinical Chemistry | 85 | 50 | $2.20 | $187 |
| 82947 Clinical Chemistry | 75 | 30 | $3.85 | $289 |
| 83036 Blood Count | 55 | 30 | $9.52 | $524 |
| 82044 Clinical Chemistry | 49 | 34 | $6.11 | $299 |
| 82570 Clinical Chemistry | 47 | 33 | $5.08 | $239 |
Medicare prescription drug claims, 2024
In 2024, the drug Menelaos Voulgaropoulos prescribed most often to Medicare patients was Gabapentin, with 377 prescriptions and refills. In total Menelaos Voulgaropoulos wrote 10,823 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 377 | 410 | 87 | $5,286 |
| Rosuvastatin Calcium Generic | 357 | 1,006 | 126 | $3,545 |
| Ezetimibe Generic | 324 | 865 | 116 | $5,915 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 289 | 289 | 65 | $347K |
| Montelukast Sodium Generic | 258 | 670 | 95 | $1,925 |
| Losartan Potassium Generic | 232 | 628 | 72 | $1,714 |
| Atorvastatin Calcium Generic | 229 | 642 | 72 | $2,003 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 226 | 232 | 72 | $4,601 |
| Amlodipine Besylate Generic | 222 | 638 | 71 | $1,191 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 198 | 198 | 45 | $5,412 |
| Topiramate Generic | 163 | 289 | 46 | $1,088 |
| Levothyroxine Sodium Generic | 160 | 430 | 50 | $1,292 |
| Farxiga Dapagliflozin Propanediol | 140 | 240 | 47 | $133K |
| Bupropion Xl Bupropion Hcl | 139 | 270 | 40 | $3,015 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 139 | 145 | 37 | $95K |
Brand drugs: 1,995 claims; generic drugs: 8,802 claims; opioid claims: 757.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Menelaos Voulgaropoulos $4,911 ($4,911 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $661.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $661 |
| Forte Bio-Pharma LLC | 16 | $544 |
| Pfizer Inc. PFE | 22 | $535 |
| Novo Nordisk Inc NVO | 21 | $479 |
| Paratek Pharmaceuticals, Inc. | 20 | $276 |
| Axsome Therapeutics, Inc. AXSM | 9 | $231 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $229 |
| Viatris Specialty LLC | 10 | $199 |
| Ardelyx, Inc. ARDX | 5 | $196 |
| Lilly USA, LLC LLY | 10 | $194 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.